Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06509503 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Combined Oral Contraceptive Pills on Migraine

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 9, 2024 (before its estimated May 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jul 15, 2024 to May 15, 2025v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators will assess the effect of combined oral contraceptive pills (COCs) on migraine features and treatment response to allow better interpretation of the exact consequence of hormonal contraceptive use on migraineurs.
Trial Details
NCT Number NCT06509503
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Migraine
Related terms Migraine Disorders
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov